Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8218-8226

  Pietra, Gabriella ^a   Mortarini, Roberta ^a   Anichini, Andrea ^a   Parmiani, Giorgio ^a  

^a Department of Experimental Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MELANOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CELL MATURATION; CONTROLLED STUDY; CORRELATION FUNCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; APOPTOSIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DENDRITIC CELLS; HUMANS; INTERLEUKIN-10; MELANOCYTES; MELANOMA; NECROSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; ULTRAVIOLET RAYS;

EID: 0035890796     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dendritic cells and the control of immunity
2. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
3. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
4. Dendritic cells acquire antigen from apoptotic cells and induce class-I restricted CTLs
5. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
6. A receptor for phosphatidylserine-specific clearance of apoptotic cells
7. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
8. CD91: A receptor for heat shock protein gp96
9. Tolerance, danger and the extended family
10. Natural adjuvants: Endogenous activators of dendritic cells
11. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
12. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
13. The induction of tolerance by dendritic cells that have captured apoptotic cells
14. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
15. Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma
16. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
17. TGF-β 1 prevents the noncognate maturation of human dendritic Langerhans cells
18. + T cells resulting in a failure to lyse tumor cells
19. 27-35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
20. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes
21. Antiapoptotic role of endogenous nitric oxide in human melanoma
22. Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism
23. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
24. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
25. Processing of engulfed apoptotic bodies yields T cell epitopes
26. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
27. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression
28. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
29. The monoclonal antibody CRI 1-351 discriminates HLA-A2 variants identified by T cells
30. Regulatory activity of autocrine IL-10 in dendritic cell functions
31. Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response
32. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
33. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules
34. Interleukin-10 production in malignant melanoma: Preferential detection of IL-10 secreting tumor cells in metastatic lesions
35. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
36. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
37. Cycling of human dendritic cell effector phenotypes in response to TNF-α modification of the current "maturation" paradigm and implications for in vivo immunoregulation
38. Secondary lymphoid tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes
39. Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: Augmentation by TNF-α and IL-1β
40. Transport of peptide-MHC class II complexes in developing dendritic cells
41. Dendritic cells capture tumor cells and present their antigens to elicit tumor-specific immune responses
42. Dead or alive: Immunogenicity of human melanoma cells when presented by dendritic cells
43. T-cell memory: You must remember this
44. Crosspriming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
45. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis
46. Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells